Literature DB >> 8713103

Differential effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18.

Y H Chen1, L H Huang, T M Chen.   

Abstract

We have studied effects of a series of progestins and estrogens on regulation of human papillomavirus (HPV) types 16 and 18 gene expression via long control region (LCR), using a transient expression assay which represented the episomal state of HPVs in precancerous lesions. Results showed that HPV gene expression induced by these steroid analogs were diverse. Gene expression via HPV16-LCR was upregulated 2-3 fold under treatment with 10(-7) M estriol, 17 beta-estradiol, and several progestins including pregnenolone, 17 alpha-hydroxy-progesterone, norethynodrel and cyproterone acetate. However, transcription via HPV18-LCR was not or weakly stimulated by these analogs. Our results can divide these analogs into HPV-enhancing and HPV-nonenhancing groups and accordingly impact the relative risk of individual oral contraceptive ingredient in cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713103     DOI: 10.1006/bbrc.1996.1080

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Estrogen and ERalpha: culprits in cervical cancer?

Authors:  Sang-Hyuk Chung; Silvia Franceschi; Paul F Lambert
Journal:  Trends Endocrinol Metab       Date:  2010-04-22       Impact factor: 12.015

Review 2.  Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

Authors:  Bansari Patel; Sonia Elguero; Suruchi Thakore; Wissam Dahoud; Mohamed Bedaiwy; Sam Mesiano
Journal:  Hum Reprod Update       Date:  2014-11-18       Impact factor: 15.610

3.  Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand.

Authors:  Morgan Marks; Patti E Gravitt; Swati B Gupta; Kai-Li Liaw; Amha Tadesse; Esther Kim; Chailert Phongnarisorn; Virach Wootipoom; Pissimai Yuenyao; Charoen Vipupinyo; Somchai Sriplienchan; David D Celentano
Journal:  J Infect Dis       Date:  2011-09-29       Impact factor: 5.226

4.  The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.

Authors:  Klaus Friese; Bernd Kost; Aurelia Vattai; Frederik Marmé; Christina Kuhn; Sven Mahner; Christian Dannecker; Udo Jeschke; Sabine Heublein
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-18       Impact factor: 4.553

5.  The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction.

Authors:  Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism.

Authors:  John H Lee; Su Min P Yi; Mary E Anderson; Kristi L Berger; Michael J Welsh; Aloysius J Klingelhutz; Michelle A Ozbun
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

7.  Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers.

Authors:  Kate Middleton; Woei Peh; Shirley Southern; Heather Griffin; Karl Sotlar; Tomomi Nakahara; Amira El-Sherif; Lesley Morris; Rashmi Seth; Merilyn Hibma; David Jenkins; Paul Lambert; Nicholas Coleman; John Doorbar
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 8.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

9.  A case-control study of endogenous hormones and cervical cancer.

Authors:  T S Shields; R T Falk; R Herrero; M Schiffman; N S Weiss; C Bratti; A C Rodriguez; M E Sherman; R D Burk; A Hildesheim
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

10.  Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.

Authors:  Kashif Rasheed; Baldur Sveinbjørnsson; Ugo Moens
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.